PRA Health Sciences launches COVID-19 monitoring program
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
Chembio Diagnostics received $4 million purchase order from Bio-Manguinhos for production of DPP COVID-19 IgM/IgG system in Brazil
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…
Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus
On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…
Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreement
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
Biotechnology | COVID-19 | Diagnostics | FDA
Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
Biotechnology | COVID-19 | Diagnostics | FDA
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
Biotechnology | COVID-19 | Diagnostics | FDA
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in Europe
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
COVID-19 | Diagnostics | NIH
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Large scale COVID-19 testing of general population begun in Iceland
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
Leading veterinary diagnostic company saw no COVID-19 cases in pets early in Pandemic
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
BioReference Laboratories offers testing for Coronavirus disease 2019 (COVID-19)
On Mar. 13, 2020, BioReference Laboratories, an OPKO company, announced it had begun accepting specimens for testing of…
Luminex provided update on SARS-CoV-2 validation testing efforts
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
COVID-19 accelerated the shift from paper forms to digital data in Vietnam
On Mar. 13, 2020, PATH and the Centers for Disease Control and Prevention (CDC) announced a collaboration with…
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMerieux
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
CerTest Biotec and BD announced COVID-19 diagnostic test
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
German lab demonstrated feasibility to detect SARS-Coronavirus-2 using Hologic’s Panther Fusion System
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
Biotechnology | CDC | COVID-19 | Diagnostics
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
LabCorp launched test for Coronavirus (COVID-19)
On Mar. 5, 2020, LabCorp announced that it was making its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test…
OPKO Health introduced Coronavirus disease (COVID-19) test
On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the…